The University Of Texas Health Science Center At San Antonio
Clinical trials sponsored by The University Of Texas Health Science Center At San Antonio, explained in plain language.
-
Lung cancer drug combo study halted after just 4 patients
Disease control TerminatedThis study aimed to see if combining two drugs, bemcentinib and pacritinib, could help people with advanced lung adenocarcinoma that had stopped responding to other treatments. Only 4 patients were enrolled before the study was terminated early, so no conclusions can be drawn abo…
Phase: PHASE1, PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Gastric cancer study in hispanics halted early
Knowledge-focused TerminatedThis study aimed to find genetic and lifestyle factors that increase the risk of gastric cancer in Hispanic people, a group that is often affected. Researchers planned to compare tumor DNA and survey responses from 129 patients. However, the study was terminated early, so results…
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:01 UTC